Response by Mahmoud et al to Letter Regarding Article, “Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents: A Meta-Analysis of Randomized Trials”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We would like to thank Dr Kounis and colleagues for the valuable comments and their interest in our work.1 Kounis et al highlighted a pathophysiological mechanism that might help to explain the higher incidence of definite/probable stent/scaffold thrombosis and very late stent/scaffold thrombosis associated with bioresorbable vascular scaffolds and seen in our meta-analysis. Indeed, our meta-analysis predominately assessed the ABSORB bioresorbable vascular scaffold stent, which is composed of synthetic aliphatic polyesters, that is, poly l-lactide and poly- …